| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| | 10-K | 10-K | 10-K | 10-K | S-1 |
| Revenues: |
| Healthcare | 605.2 | 552.0 | 467.0 | 359.8 | |
| Global Retail and Other | 73.4 | 73.1 | 74.3 | 81.5 | |
| Total revenues | 678.7 | 625.2 | 541.3 | 441.4 | 160.2 |
| Revenue growth [+] | 8.6% | 15.5% | 22.7% | 175.5% | |
| Healthcare | 9.6% | 18.2% | 29.8% | | |
| Global Retail and Other | 0.4% | -1.6% | -8.9% | | |
| Cost of goods sold [+] | 610.4 | 600.7 | 480.0 | 408.0 | 0.0 |
| Labor costs | 334.6 | 326.7 | 254.6 | 214.3 | |
| Other cost of sales | 24.7 | 22.2 | 20.8 | 14.5 | |
| Cost of services, excluding D&A | 251.1 | 251.8 | 204.6 | 179.1 | |
| Gross profit | 68.3 | 24.5 | 61.3 | 33.4 | 160.2 |
| Gross margin | 10.1% | 3.9% | 11.3% | 7.6% | 100.0% |
| Selling, general and administrative [+] | 244.9 | 216.2 | 202.7 | 135.3 | 21.7 |
| General and administrative | | | | | 21.7 |
| Other operating expenses | -425.4 | -406.7 | -339.9 | -271.6 | 56.4 |
| EBITDA [+] | 248.8 | 214.9 | 198.5 | 169.7 | 82.1 |
| EBITDA growth | 15.8% | 8.3% | 16.9% | 106.7% | |
| EBITDA margin | 36.7% | 34.4% | 36.7% | 38.5% | 51.3% |
| Depreciation and amortization | 25.6 | 20.2 | 12.7 | 7.4 | 9.2 |
| EBITA | 223.2 | 194.8 | 185.8 | 162.3 | 73.0 |
| EBITA margin | 32.9% | 31.2% | 34.3% | 36.8% | 45.5% |
| Amortization of intangibles | 59.6 | 60.8 | 61.5 | 52.4 | |
| EBIT [+] | 163.6 | 134.0 | 124.4 | 110.0 | 73.0 |
| EBIT growth | 22.1% | 7.7% | 13.1% | 50.7% | |
| EBIT margin | 24.1% | 21.4% | 23.0% | 24.9% | 45.5% |
| Non-recurring items [+] | 1.3 | | 27.8 | 79.8 | |
| Asset impairment | 1.3 | | 27.8 | 74.0 | |
| Interest expense | 34.9 | 48.7 | 65.6 | 51.7 | 5.8 |
| Interest expense | 34.9 | 48.7 | 65.6 | 51.7 | 5.8 |
| Other income (expense), net [+] | -1.0 | -15.5 | -3.3 | -21.1 | -1.1 |
| Gain (loss) on debt retirement | -3.2 | -16.4 | -4.1 | -21.5 | |
| Other | 2.2 | 0.9 | 0.8 | 0.4 | |
| Pre-tax income | 126.4 | 69.8 | 27.7 | -42.6 | 66.0 |
| Income taxes | -11.8 | 21.0 | 14.4 | -16.8 | 24.2 |
| Tax rate | | 30.0% | 52.0% | 39.4% | 36.7% |
| Net income | 138.2 | 48.9 | 13.9 | -25.8 | 41.8 |
| Net margin | 20.4% | 7.8% | 2.6% | -5.9% | 26.1% |
| |
| Basic EPS [+] | $1.50 | $0.57 | $0.17 | ($0.40) | |
| Growth | 161.7% | 233.4% | -143.5% | | |
| Diluted EPS [+] | $1.45 | $0.55 | $0.17 | ($0.40) | |
| Growth | 163.5% | 221.9% | -143.3% | | |
| |
| Dividends per share [+] | | $1.76 | | | |
| Growth | -100.0% | | | | |
| |
| Shares outstanding (basic) [+] | 91.9 | 85.1 | 77.2 | 65.3 | |
| Growth | 8.1% | 10.2% | 18.3% | | |
| Shares outstanding (diluted) [+] | 95.1 | 88.6 | 77.6 | 65.3 | |
| Growth | 7.4% | 14.1% | 19.0% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |